Key result
Administration of edetate disodium instead of edetate calcium disodium during chelation therapy for autism caused profound hypocalcemia and fatal cardiac arrest in 1 five-year-old boy.
Case Report (n=1)
Administration of edetate disodium instead of edetate calcium disodium for chelation therapy can cause profound hypocalcemia leading to fatal cardiac arrest in children.
Answers are grounded in this paper and cite their sources.
Substitution with edetate disodium risks fatal hypocalcemia; this case leaves open the incidence of such errors in chelation.
BACKGROUND: Chelation therapy has emerged as a popular treatment modality to remove heavy metals that are thought to cause autism. We report a fatality that occurred as a consequence of chelation therapy for autism when the incorrect form of EDTA was administered. CASE REPORT: A five-year-old autistic male was being chelated in a physician's office. While receiving his third treatment he went into cardiac arrest. It was not determined until after the child's death that he had been given edetate disodium rather than edetate calcium disodium, causing profound hypocalcemia and triggering the cardiac events that led to his death. DISCUSSION: In 1991, the CDC recommended using only edetate calcium disodium, not edetate disodium, to children because edetate disodium may induce tetany and possible hypocalcemia as illustrated in this case. CONCLUSION: The use of chelation therapy in autistic children has not been validated and can have tragic consequences.
No takes yet. Share an insight, caveat, or question.
Baxter et al. (2008) conducted a case report in autism (n=1). edetate disodium was evaluated on cardiac arrest and death. Administration of edetate disodium instead of edetate calcium disodium during chelation therapy for autism caused profound hypocalcemia and fatal cardiac arrest in 1 five-year-old boy.
Synapse has enriched 10 related papers. Consider them for comparative context: